← Back to Search

Dietary Supplement

Dietary supplement and intermittent fasting regimen for Healthy Subjects

N/A
Waitlist Available
Led By Dawn Beckman, MD
Research Sponsored by Unicity International, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Body mass index (BMI) ≥25.0 to <35.0 kg/m2
Waist circumference >102 cm for men and >88 cm for women
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 days
Awards & highlights

Study Summary

This trial will test the effect of a nutritional supplement and fasting regimen on blood sugar levels in people at risk for diabetes.

Eligible Conditions
  • Healthy Subjects
  • Prediabetes

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Glycemic variability
Secondary outcome measures
Daytime and Overall Blood Glucose Levels
Daytime glycemic variability
Gastrointestinal symptoms
+3 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Phase 2Experimental Treatment1 Intervention
A four-day period during which subjects will take a yerba mate supplement once per day in the morning and a fiber-based supplement twice per day prior to two meals, while also practicing daily intermittent fasting (16 hours fasting, 8 hours eating window).
Group II: Phase 1Experimental Treatment1 Intervention
A four-day period during which subjects will take a yerba mate supplement once per day in the morning and a fiber-based supplement twice per day prior to two meals.
Group III: BaselineActive Control1 Intervention
A baseline period (no supplements or intermittent fasting).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dietary supplement regimen
2022
N/A
~50

Find a Location

Who is running the clinical trial?

Unicity International, Inc.Lead Sponsor
Biofortis Innovation ServicesUNKNOWN
2 Previous Clinical Trials
144 Total Patients Enrolled
Dawn Beckman, MDPrincipal InvestigatorBiofortis Innovation Services
8 Previous Clinical Trials
435 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~19 spots leftby Mar 2025